Table 2. Summary of case series for jejunal interpositions.
Author | # of patients | OR time (min) | EBL (mL) | Graft loss (%) | Leak rate (%) | Stricture rate (%) | Respiratory complication rate (%) | Reoperation rate (%) | 30 day mortality (%) | PO tolerance (%) |
---|---|---|---|---|---|---|---|---|---|---|
Ninomiya (2014) (10) | 13 | 715 | 730 | NR | 0 | 23.1 | 23.1 | NR | 0 | NR |
Doki (2008) (14) | 25 | 666 | 1,185 | NR | 24 | NR | 8 | NR | NR | NR |
Blackmon (2014) (22) | 60 | NR | NR | 8.3 | 32 | NR | 30 | 31.7 | 5 | 93.3 |
Iwata (2012) (25) | 27 | 636 | 580 | 0 | 7.4 | 3.7 | 7.4 | 3.7 | 0 | 100 |
Baker (2015) (27) | 6 | NR | 1,200 | 0 | 16.7 | 50 | 33.3 | 66.7 | 0 | 80 |
Shirakawa (2015) (28) | 53 | NR | NR | 0 | 7.5 | 7.5 | NR | NR | NR | NR |
Poh (2011) (29) | 51 | NR | NR | 5.9 | 11.7 | 9.8 | 37.3 | 15.7 | 0 | 90 |
Barzin (2011) (30) | 5 | 467 | NR | 0 | 20 | NR | NR | 20 | 0 | 100 |
Ascioti (2005) (31) | 26 | 726 | 1,441 | 7.7 | 19.2 | NR | 30.8 | 11.5 | 0 | 95.2 |
Chana (2002) (32) | 11 | NR | NR | 0 | 36.4 | 18.2 | NR | 90.9 | 0 | 100 |
EBL, estimated blood loss; NR, not reported; OR, odds ratio; PO, oral.